Seminari di Ematologia Oncologica - Società Italiana di Ematologia

n BIBLIOGRAFIA
1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA,
Stein H, Thiele J, Vardiman JW. WHO Classification of
tumours of haematopoietic and lymphoid tissues, fourth
edition. IARC WHO Classification of Tumours, No 2 ed
2008.
2. Murphy SB. Childhood non-Hodgkin’s lymphoma. The
New England journal of medicine. 1978; 299: 1446-8.
3. Faderl S, Jeha S, Kantarjian HM. The biology and therapy
of adult acute lymphoblastic leukemia. Cancer.
2003; 98: 1337-54.
4. Smith OP, Hann I. Pathology of leukemia. Pediatric
Oncology. 3rd ed. London: Arnold 2004; 83-100.
5. Pui CH, Ribeiro RC, Hancock ML, Rivera GK, Evans
WE, Raimondi SC, et al. Acute myeloid leukemia in children
treated with epipodophyllotoxins for acute lymphoblastic
leukemia. N Eng J Med. 1991; 325: 1682-
7.
6. Zuna J, Cave H, Eckert C, Szczepanski T, Meyer C,
Mejstrikova E, et al. Childhood secondary ALL after ALL
treatment. Leukemia. 2007; 21: 1431-5.
7. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton
DA, Gralnick HR, et al. Proposals for the classification
of the acute leukaemias. French-American-British
(FAB) co-operative group. Br J Haematol. 1976; 33:
451-8.
8. Sander CA, Jaffe ES, Gebhardt FC, Yano T, Medeiros
LJ. Mediastinal lymphoblastic lymphoma with an immature
B-cell immunophenotype. Am J Surg Pathol. 1992;
16: 300-5.
9. Riley RS, Massey D, Jackson-Cook C, Idowu M,
Romagnoli G. Immunophenotypic analysis of acute
lymphocytic leukemia. Hematol/Oncol Clin. 2002; 16:
245-99.
10. Chetty R, Pulford K, Jones M, Mathieu-Mahul D, Close
P, Hussein S, et al. SCL/Tal-1 expression in T-acute lymphoblastic
leukemia: an immunohistochemical and
genotypic study. Human pathology. 1995; 26: 994-8.
11. Lewis RE, Cruse JM, Sanders CM, Webb RN, Tillman
BF, Beason KL, et al. The immunophenotype of pre-
TALL/LBL revisited. Exp Mol Pathol. 2006; 81: 162-5.
12. Faderl S, Kantarjian HM, Talpaz M, Estrov Z. Clinical
significance of cytogenetic abnormalities in adult acute
lymphoblastic leukemia. Blood. 1998 ; 91: 3995-4019.
13. Moorman AV, Harrison CJ, Buck GA, Richards SM,
Secker-Walker LM, Martineau M, et al. Karyotype is an
independent prognostic factor in adult acute lymphoblastic
leukemia (ALL): analysis of cytogenetic data
from patients treated on the Medical Research Council
(MRC) UKALLXII/Eastern Cooperative Oncology Group
(ECOG) 2993 trial. Blood. 2007; 109: 3189-97.
14. Mullighan CG, Miller CB, Radtke I, Phillips LA, Dalton
J, Ma J, et al. BCR-ABL1 lymphoblastic leukaemia is
characterized by the deletion of Ikaros. Nature. 2008;
453: 110-4.
15. Iacobucci I, Lonetti A, Messa F, Cilloni D, Arruga F,
Linfoma linfoblastico dell’adulto
Ottaviani E, et al. Expression of spliced oncogenic
Ikaros isoforms in Philadelphia-positive acute lymphoblastic
leukemia patients treated with tyrosine
kinase inhibitors: implications for a new mechanism of
resistance. Blood. 2008; 112: 3847-55.
16. Mancini M, Scappaticci D, Cimino G, Nanni M,
Derme V, Elia L, et al. A comprehensive genetic classification
of adult acute lymphoblastic leukemia (ALL):
analysis of the GIMEMA 0496 protocol. Blood. 2005;
105: 3434-41.
17. Zhu YM, Zhao WL, Fu JF, Shi JY, Pan Q, Hu J, et al.
NOTCH1 mutations in T-cell acute lymphoblastic
leukemia: prognostic significance and implication in
multifactorial leukemogenesis. Clin Cancer Res. 2006;
12: 3043-9.
18. Paulsson K, Cazier JB, Macdougall F, Stevens J,
Stasevich I, Vrcelj N, et al. Microdeletions are a general
feature of adult and adolescent acute lymphoblastic
leukemia: unexpected similarities with
pediatric disease. Proceedings of the National
Academy of Sciences of the United States of America.
2008; 105: 6708-13.
19. Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard
C, Raimondi SC, et al. Gene expression signatures
define novel oncogenic pathways in T cell acute lymphoblastic
leukemia. Cancer Cell. 2002; 1: 75-87.
20. Lin YW, Aplan PD. Gene expression profiling of precursor
T-cell lymphoblastic leukemia/lymphoma identifies
oncogenic pathways that are potential therapeutic
targets. Leukemia. 2007; 21: 1276-84.
21. Martinez-Delgado B, Melendez B, Cuadros M, Alvarez
J, Castrillo JM, Ruiz De La Parte A, et al. Expression
profiling of T-cell lymphomas differentiates peripheral
and lymphoblastic lymphomas and defines survival
related genes. Clin Cancer Res. 2004; 10: 4971-82.
22. Raetz EA, Perkins SL, Bhojwani D, Smock K, Philip M,
Carroll WL, et al. Gene expression profiling reveals
intrinsic differences between T-cell acute lymphoblastic
leukemia and T-cell lymphoblastic lymphoma.
Pediatr Blood Cancer. 2006; 47: 130-40.
23. Uyttebroeck A, Vanhentenrijk V, Hagemeijer A, Boeckx
N, Renard M, Wlodarska I, et al. Is there a difference
in childhood T-cell acute lymphoblastic leukaemia and
T-cell lymphoblastic lymphoma? Leuk Lymphoma.
2007; 48: 1745-54.
24. A clinical evaluation of the International Lymphoma
Study Group classification of non-Hodgkin’s lymphoma.
The Non-Hodgkin’s Lymphoma Classification Project.
Blood. 1997; 89: 3909-18.
25. Slater DE, Mertelsmann R, Koziner B, Higgins C,
McKenzie S, Schauer P, et al. Lymphoblastic lymphoma
in adults. J Clin Oncol. 1986; 4: 57-67.
26. Hoelzer D, Gokbuget N, Digel W, Faak T, Kneba M,
Reutzel R, et al. Outcome of adult patients with T-lymphoblastic
lymphoma treated according to protocols
for acute lymphoblastic leukemia. Blood. 2002; 99:
4379-85.
57